GabrielNMannisMD

Hematology • Stanford, CA

Assistant Professor of Medicine, Stanford Cancer Institute

Join to view full profile

Dr. Mannis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Mannis' full profile

Already have an account?

Office
Stanford Cancer Center
875 Blake Wilbur Drive
Stanford, CA 94305
Phone+1 650-498-6000
Is this information wrong?

Education & Training

University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2011 - 2014
University of California (San Francisco)Residency, Internal Medicine, 2008 - 2011
University of California, Davis, School of MedicineClass of 2008

Certifications & Licensure

CA State Medical License 2010 - 2026

Clinical Trials

Magrolimab Monotherapy or Magrolimab in Combination With Azacitidine in Participants With Hematological Malignancies Start of enrollment: 2017 Sep 08
Terminated
Phase 1
Study to Determine the Efficacy of Uproleselan (GMI-1271) in Combination With Chemotherapy to Treat Relapsed/Refractory Acute Myeloid Leukemia Start of enrollment: 2018 Oct 15
Active, not recruiting
Phase 3
Pharmacokinetics, Safety, and Efficacy of ASTX727 in Combination With Venetoclax in Acute Myeloid Leukemia (AML) Start of enrollment: 2021 Feb 09
Active, not recruiting
Phase 1, Phase 2
A Phase 1b Master Trial to Investigate CPX-351 in Subjects With Previously Untreated Acute Myeloid Leukemia Start of enrollment: 2019 Dec 02
Completed
Phase 1
Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia Start of enrollment: 2022 Jun 01
Recruiting
Not Applicable
Roles: Contact
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia Start of enrollment: 2019 Mar 11
Recruiting
Phase 1, Phase 2
Roles: Contact, Principal Investigator
Venetoclax + Azacitidine vs. Induction Chemotherapy in AML Start of enrollment: 2021 May 20
Recruiting
Phase 2
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

p53 immunohistochemistry as an ancillary tool for rapid assessment of residual disease in TP53-mutated acute myeloid leukemia and myelodysplastic syndromes.
Eula Fung, Nivaz Brar, Lauren Lawrence, James L Zehnder, Peter L Greenberg, Gabriel N Mannis, Tian Y Zhang, Dita Gratzinger, Jean Oak, Oscar Silva, Jason Kurzer, Brent...> ;American Journal of Clinical Pathology. 2024 Apr 20
1 citations
CD38 and BCL2 expression guides treatment with daratumumab and venetoclax in tagraxofusp-refractory blastic plasmacytoid dendritic cell neoplasm (BPDCN) featuring dyna...
Xiaoyi Hu, Asiri Ediriwickrema, Atif Saleem, Brent Tan, Naveen Pemmaraju, Gabriel N Mannis> ;Leukemia Research. 2024 Apr 1
Treatment of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN): focus on the use of tagraxofusp and clinical considerations.
Fazal, S., Naveen Pemmaraju, Yazan F Madanat, David Rizzieri, Salman Fazal, Raajit Rampal, Gabriel Mannis, Eunice S Wang, James Foran, Andrew A Lane> ;Leukemia & Lymphoma. 2024 May 1
Measurable residual disease conversion rate with consolidation chemotherapy in acute myeloid leukemia.
Daria Gaut, Caspian Oliai, Jonathan Boiarsky, Shiliang Zhang, Amandeep Salhotra, Tali Azenkot, Vanessa E Kennedy, Vishesh Khanna, Karla Olmedo Gutierrez, Navika Shukla...> ;Leukemia & Lymphoma. 2024 Jan 1
4 citations
Tolerability and Efficacy of the Anticluster of Differentiation 47 Antibody Magrolimab Combined With Azacitidine in Patients With Previously Untreated AML: Phase Ib Re...
Naval G Daver, Paresh Vyas, Suman Kambhampati, Monzr M Al Malki, Richard A Larson, Adam S Asch, Gabriel Mannis, Wanxing Chai-Ho, Tiffany N Tanaka, Terrence J Bradley, ...> ;Journal of Clinical Oncology. 2023 Nov 1
Association of geriatric measures and global frailty with cognitive decline after allogeneic hematopoietic cell transplantation in older adults.
Li-Wen Huang, Ying Shi, Charalambos Andreadis, Aaron C Logan, Gabriel N Mannis, Catherine C Smith, Karin M L Gaensler, Thomas G Martin, Lloyd E Damon, W John Boscardin...> ;Journal of Geriatric Oncology. 2023 Nov 1
4 citations
Standardising acute myeloid leukaemia classification systems: a perspective from a panel of international experts.
Shallis, R., Daver, N., Altman, J., Komrokji, R., Pollyea, D., Badar, T., Bewersdorf, J., Bhatt, V., de Botton, S., de la Fuente Burguera, A., Carraway, H., Desai, P.,...> ;The Lancet. Haematology. 2023 Sep 1
1 citations
Outcomes with molecularly targeted agents as salvage therapy following frontline venetoclax + hypomethylating agent in adults with acute myeloid leukemia: A multicente...
Vishesh Khanna, Tali Azenkot, Selina Qiuying Liu, Jason Gilbert, Edna Cheung, Kimberly Lau, Daniel A Pollyea, Elie Traer, Brian A Jonas, Tian Y Zhang, Gabriel N Mannis> ;Leukemia Research. 2023 Aug 1
Leukostasis-induced digital ischemia.
Alec Hasty, Mugdha Joshi, Dasom Lee, Gabriel N Mannis> ;Ejhaem. 2023 May 1
1 citations
Older Adults With Newly Diagnosed AML: Hot Topics for the Practicing Clinician.
Catherine Lai, Rahul S Bhansali, Eric J Kuo, Gabriel Mannis, Richard J Lin> ;American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2023 May 1
17 citations
Acute Myeloid Leukemia, Version 3.2023, NCCN Clinical Practice Guidelines in Oncology.
Daniel A Pollyea, Jessica K Altman, Rita Assi, Dale Bixby, Amir T Fathi, James M Foran, Ivana Gojo, Aric C Hall, Brian A Jonas, Ashwin Kishtagari, Jeffrey Lancet, Lori...> ;Journal of the National Comprehensive Cancer Network. 2023 May 1
The Goldilocks Dilemma in AML: Too Young and Fit, but Not Young and Fit Enough.
Emma C St Martin, Tian Yi Zhang, Gabriel N Mannis> ;Clinical Lymphoma, Myeloma & Leukemia. 2023 Jun 1
Value of embedded palliative care: outpatient palliative care and health care utilization for patients with hematologic malignancies.
Mazie Tsang, Kara Bischoff, Kelly L Schoenbeck, Kim Berry, David O'Riordan, Bita Fakhri, Sandy W Wong, Nina Shah, Rebecca Olin, Charalambos Andreadis, Jules Vieaux, Ev...> ;Blood Advances. 2023 Jul 11
15 citations
North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need.
Naveen Pemmaraju, Hagop Kantarjian, Kendra Sweet, Eunice Wang, Jayastu Senapati, Nathaniel R Wilson, Marina Konopleva, Arthur E Frankel, Vikas Gupta, Ruben Mesa, Matth...> ;Blood. 2023 Feb 9
7 citations
Outcomes of allogeneic transplantation after hypomethylating agents with venetoclax in acute myeloid leukemia.
Vanessa E Kennedy, Gavin Hui, Tali Azenkot, Daria Gaut, Matthew J Wieduwilt, Caspian Oliai, Brian A Jonas, Varun Mittal, Aaron C Logan, Lori S Muffly, Gabriel N Mannis> ;American Journal of Hematology. 2022 Jun 1
2 citations
Patterns and Predictors of Functional Decline after Allogeneic Hematopoietic Cell Transplantation in Older Adults.
Li-Wen Huang, Ying Sheng, Charalambos Andreadis, Aaron C Logan, Gabriel N Mannis, Catherine C Smith, Karin M L Gaensler, Thomas G Martin, Lloyd E Damon, Chiung-Yu Huan...> ;Transplantation and Cellular Therapy. 2022 Jun 1
14 citations
Characterisation of infections in patients with acute myeloid leukaemia receiving venetoclax and a hypomethylating agent.
Sandy On, Carolyn G Rath, Michelle Lan, Bobby Wu, Kimberly M Lau, Edna Cheung, William Alegria, Rebecca Young, Marisela Tan, Carrie Kim, Jennifer Phun, Nimish Patel, G...> ;British Journal of Haematology. 2022 Apr 1
Correction to: Measurable residual disease status and FLT3 inhibitor therapy in patients with FLT3-ITD mutated AML following allogeneic hematopoietic cell transplantat...
Emily C Liang, Connie Chen, Rong Lu, Gabriel N Mannis, Lori Muffly> ;Bone Marrow Transplantation. 2022 Apr 1
9 citations
Measurable residual disease status and FLT3 inhibitor therapy in patients with FLT3-ITD mutated AML following allogeneic hematopoietic cell transplantation.
Emily C. Liang, Connie Chen, Rong Lu, Gabriel N. Mannis, Lori Muffly> ;Bone Marrow Transplantation. 2021 Sep 28
3 citations
Inhibition of MET Signaling with Ficlatuzumab in Combination with Chemotherapy in Refractory AML: Clinical Outcomes and High-Dimensional Analysis
Victoria E. Wang, Bradley W. Blaser, Ravi K. Patel, Gregory K. Behbehani, Arjun A. Rao, Blythe Durbin-Johnson, Tommy Jiang, Aaron C Logan, Matthew L. Settles, Gabriel ...> ;Blood Cancer Discovery. 2021 Jul 16
1 citations
Epstein–Barr virus-positive lymphoproliferative disorder manifesting as pulmonary disease in a patient with acute myeloid leukemia: a case report
Ritika Dutta, Susanna Y. Miao, Paul Phan, Sebastian Fernandez-Pol, Parveen Shiraz, Dora Y. Ho, Gabriel N. Mannis, Tian Y. Zhang> ;Journal of Medical Case Reports. 2021 Mar 28
4 citations
Routine use of gemtuzumab ozogamicin in 7 + 3-based inductions for all 'non-adverse' risk AML.
Abdullah Ladha, Gavin Hui, Edna Cheung, Caroline Berube, Steven Coutre, Jason Gotlib, Michaela Liedtke, Tian Y. Zhang, Lori Muffly, Gabriel N. Mannis> ;Leukemia & Lymphoma. 2021 Jan 24
152 citations
Acute Myeloid Leukemia, Version 2.2021 Featured Updates to the NCCN Guidelines
Daniel A. Pollyea, Dale L. Bixby, Alexander E. Perl, Vijaya Raj Bhatt, Jessica K. Altman, Frederick R. Appelbaum, Marcos de Lima, Amir T. Fathi, James M. Foran, Ivana ...> ;Journal of the National Comprehensive Cancer Network. 2021 Jan 6
40 citations
Hematopoietic Cell Transplantation in the Treatment of Newly Diagnosed Adult Acute Myeloid Leukemia: An Evidence-Based Review from the American Society of Transplantat...
Bhagirathbhai Dholaria, Bipin N. Savani, Betty K. Hamilton, Betul Oran, Hien D. Liu, Martin S. Tallman, Stefan O. Ciurea, Noa G. Holtzman, Gordon L. Phillips, Steven M...> ;Transplantation and Cellular Therapy. 2021 Jan 1
4 citations
Serial comprehensive geriatric and quality of life assessments in adults age ≥ 50 years undergoing autologous hematopoietic cell transplantation
Mariam T. Nawas, Ying Sheng, Chiung Yu Huang, Charalambos Andreadis, Thomas G. Martin, Jeffrey L. Wolf, Weiyun Z. Ai, Lawrence D. Kaplan, Gabriel N. Mannis, Aaron C Lo...> ;Journal of Geriatric Oncology. 2021 May 1
Join now to see all

Lectures

Adult Clinical Malignant Hematology
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

OncLive® Presents State of the Science Summit™: Hematologic MalignanciesDecember 5th, 2017
Risk-Reducing Salpingo-Oophorectomy and Ovarian Cancer Screening in 1077 Women After BRCA TestingJanuary 28th, 2013
Study Examines Risk Reduction and Screening for Ovarian Cancer Among Women Following BRCA TestingJanuary 29th, 2016